Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

AbbVie

Status: Completed

Conditions: Parkinson's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT02906488

P15-720

Details and patient eligibility

About

The purpose of this study is to assess the safety and efficacy of long-term use of Duodopa in patients with Parkinkon's disease in actual usage

Enrollment: 839 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with Parkinson's disease using Duodopa for the purpose of improving circadian change (wearing-off phenomenon) of symptoms of Parkinson's disease in which sufficient effect cannot be obtained with existing drug therapy including levodopa-containing drugs.

Exclusion criteria

NA

Trial design

839 participants in 1 patient group

Patients with Parkinson's Disease